Gene Query: GMEB1

Dataset Description Geneva Score
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 10.09
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 10.09
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 9.79
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 8.92
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.74
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 6.69
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 6.58
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 6.57
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 6.51
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 6.51
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 6.39
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 6.17
RNA expression analysis upon JMJD1C depletion 6.08
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 6.08
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.82
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 5.67
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 5.62
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 5.56
A role for ZNF598 in post-transcriptional gene regulation 5.54
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 5.35
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 5.29
T47D RNA-seq and ChrRNA-seq data 5.29
Primary Human B-cell Temporal Response to CD40L Stimulation 5.26
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.13
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 5.1
RNA m5C Methylation in breast cancer using MeRIP-Seq 4.92
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 4.88
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 4.88
Cleavage Factor Im as a key regulator of 3’ UTR length 4.81
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 4.79
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 4.79
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 4.74
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 4.69
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 4.69
Integrating single-cell transcriptomic data across different conditions, technologies, and species 4.67
Gene expression in PANC1 cells treated with Rakicidin 4.66
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 4.64
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.6
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 4.57
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.52
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 4.47
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 4.46
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.45
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.45
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 4.35
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 4.35
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 4.16
Human neutrophil genome during PMA- and E. coli encounter-induced activation 4.14
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 4.14
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.14
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 4.13
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 4.12
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 4.12
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 4.11
RNAseq Study in CC-671 Treated Cal-51 Cells 4.05
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 4.04
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 3.97
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 3.97
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 3.94
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 3.88
RIG-I and MDA5 fRIP during KSHV lytic reactivation 3.88
HNF1A deficiency impairs β-cell fate, granule maturation and function 3.81
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 3.81
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 3.71
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 3.68
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.67
PTHrP overexpression in MCF7 cells 3.65
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 3.63
Identification of global regulators of T-helper cell lineage specification 3.63
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 3.61
CD95/Fas ligand mRNA is toxic to cells 3.59
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 3.55
RNAseq Analysis in glioblastoma cells treated with Mepazine 3.45
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 3.39
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 3.33
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 3.33
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 3.32
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 3.32
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 3.29
Capturing the Interactome of Newly Transcribed RNA 3.27
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.27
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 3.25
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 3.23
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 3.09
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 3.09
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.06
Identification of renal resident macrophages across species 3.02
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.01
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 3.01
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 2.96
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 2.96
CROP-Seq in Primary Human T Cells 2.94
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 2.94
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.85
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.85
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 2.85
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 2.83
SLAM-seq for K562 endogenous mRNA decay 2.82
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 2.74
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 2.72
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 2.7
Total RNA-seq in ALL-SIL upon JQ1 inhibition 2.7
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 2.66
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 2.66
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.66
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.66
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 2.64
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 2.61
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 2.6
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 2.59
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 2.58
BAF controls genome accessibility 2.57
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.57
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.54
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.5
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 2.47
Effect of drugs on transcriptomic profiles 2.45
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 2.43
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 2.41
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.41
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.39
SRSF2 mutations impair hematopoiesis and alter exon recognition 2.39
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.38
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 2.37
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 2.36
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.36
Transcriptional profiling of LS1034 cells treated with tepoxalin 2.35
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 2.35
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 2.34
UV_24h_GRO-Seq 2.32
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 2.31
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 2.31
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 2.28
Tracking of dCas9-methyltransferase footprints 2.28
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 2.27
SNHG5 siRNA knock down in HCT116 cells 2.24
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.23
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 2.23
Single-Cell Genotyping of Transcriptomes 2.22
RNA-seq of Single-Cell Genotyping of Transcriptomes 2.22
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 2.2
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 2.19
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 2.14
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 2.13
Transcriptome analysis in Neobractatin treated cells 2.12
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 2.11
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 2.1
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 2.1
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 2.09
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 2.08
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 2.05
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 2.03
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 2.03
EP400 is required for Max and MCPyV mediated gene activation 2.03
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.02
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.02
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.0
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 2.0
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 1.99
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 1.97
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 1.97
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 1.97
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 1.96
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 1.94
Transcriptional landscape changes during human embryonic stem cell derivation 1.93
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.92
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 1.9
Seletive inhibition of CDK9 in DLBCL cell lines 1.89
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 1.89
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 1.89
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 1.89
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 1.88
The evolution of N6-methyladenosine in primates 1.87
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 1.87
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.87
LNCaP treated with iBET 1.86
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 1.84
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 1.83
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.81
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.8
Global response to chemotherapy-induced apoptosis 1.79
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 1.79
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 1.78
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 1.77
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.75
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 1.75
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 1.75
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 1.75
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 1.74
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 1.73
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 1.73
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 1.73
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 1.72
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 1.72
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 1.71
mRNA expression profile of Lymphocytes 1.7
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 1.7
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 1.69
Irf9 function in immunity in mouse 1.69
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.69
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.69
Measure transcript integrity using RNA-seq data 1.67
Genetic-to-epigenetic Therapy for Pancreatic Cancer 1.66
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 1.66
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.66
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 1.65
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.65
PRDM1 inhibits proliferation of human colon cancer organoids 1.64
circRNA-sequencing 1.62
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 1.61
Global transcriptome analysis of HAP1 cells 1.6
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 1.6
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 1.6
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.59
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.58
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.58
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 1.55
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 1.55
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 1.55
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 1.55
Identification of HOXB13 target genes responsive to BET inhibitors 1.55
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 1.54
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.52
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.52
Neonatal and adult human testis defined at the single-cell level 1.52
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.52
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 1.52
SETBP1-WT and SETBP1-G870S epigenetic landscapes 1.52
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 1.51
Transcription control by the ENL YEATS domain in acute leukemia 1.51
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 1.5
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 1.47
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 1.45
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.44
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 1.43
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 1.42
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.42
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.42
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.41
Generating Patterned Kidney Organoids for Studying Development and Diseases 1.41
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.4
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 1.39
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.39
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.39
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 1.37
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 1.37
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 1.36
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 1.35
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 1.34
Modulation of nonsense-mediated decay by rapamycin 1.34
RNA polymerase in pre-B-ALL cell lines 1.33
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 1.32
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.3
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.3
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.3
SLIGRL-induced gene expression changes in NHEK cells 1.29
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 1.29
Effect of BMP inhibition or stimulation of primary human keratinocytes 1.27
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 1.27
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.25
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 1.24
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 1.24
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.24
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.24
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.23
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.23
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.23
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.23
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 1.23
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 1.21
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 1.21
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 1.19
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.18
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.18
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 1.18
Effect of PRDM11 depletion in U2932 cells 1.18
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.17
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.17
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.17
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.17
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 1.16
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 1.16
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 1.14
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 1.14
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.14
RNA-seq of cancer cell lines treated with T-025 1.14
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 1.13
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.12
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 1.07
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 1.05
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.04
Loss of CREBBP results in gene expression repression in lymphoma cells 1.04
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 1.03
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 1.02
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.01
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 1.01
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 1.01
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 1.0
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.0
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 1.0
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.0
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.0
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 1.0
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.0
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.99
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.99
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 0.98
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.96
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.96
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 0.96
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.96
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 0.95
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 0.95
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.95
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 0.95
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 0.94
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.93
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 0.92
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 0.92
Transcriptional profile in human S. haematobium infection 0.91
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.91
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 0.9
Landscape and variation of RNA secondary structure across the human transcriptome 0.9
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 0.9
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 0.9
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.9
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.9
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 0.89
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.89
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.89
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 0.89
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.88
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.88
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.88
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.87
TT-Seq captures the human transient transcriptome 0.87
Dissecting neural differentiation regulatory networks through epigenetic footprinting 0.86
Role of COP1 on MAP kinase transcriptional output in melanoma 0.85
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.84
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.81
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.79
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.78
Single cell transcriptome of peritoneal cells 0.78
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 0.77
MicroRNA-125a-5p overexpression in human macrophages 0.77
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.77
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.77
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.76
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.76
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.76
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.75
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.75
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.74
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.74
Oncogenic roles of ARID5B in T-ALL 0.74
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.73
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.71
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 0.71
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 0.71
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 0.71
Transcriptome-wide modulation of splicing by the exon junction complex 0.71
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 0.69
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 0.69
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.68
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.67
Anti-inflammatory effect of indoleacrylic acid (IA) 0.67
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.66
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.66
Triple vectors expand AAV transfer capacity in the retina 0.65
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.65
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.65
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.61
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.6
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.6
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.59
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 0.59
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.58
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 0.58
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 0.57
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.53
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.52
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.52
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.51
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.51
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 0.5
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.5
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.5
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.5
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.49
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.49
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.49
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.49
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.48
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.48
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 0.47
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.47
hNSCs siRNA NOVA2 0.47
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.46
HNRNPM-regulated splicing dependencies in prostate cancer 0.46
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.46
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.46
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.46
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.46
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.45
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.45
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.45
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 0.44
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.43
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 0.42
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.42
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.42
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.42
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.39
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.39
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.39
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.38
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.38
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 0.38
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 0.38
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.35
Stem and effector CD8 T-cells from human cancers 0.35
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 0.34
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.34
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.33
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.33
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.32
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.31
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.31
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.27
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.27
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.27
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.27
High-throughput sequencing of pluripotent cells 0.27
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.27
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.26
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.26
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.26
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 0.25
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.25
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.24
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 0.23
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.22
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.22
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.2
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 0.19
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 0.19
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.19
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.19
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 0.17
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 0.17
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.17
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 0.17
Identification of a LIF-responsive replication-competent human β cell 0.17
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.17
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.16
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.15
A single-cell transcriptome atlas of the human pancreas 0.15
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.14
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.14
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.14
RNA-seq analysis of differentiating human erythroblasts 0.14
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.13
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.13
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.13
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.13
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.13
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.12
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 0.12
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.12
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.12
DART-seq: an antibody-free method for global m6A detection 0.11
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.11
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.11
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.11
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.1
RNA-seq of primary patient AML samples 0.09
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.08
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.08
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.08
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.08
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.08
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.07
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.07
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.07
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.07
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.07
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.06
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.06
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.06
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.05
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.04
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.04
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.03
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.01
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 0.01
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.01
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.01
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation